{"id":{"repo_id":"mit","oai_identifier":"oai:dspace.mit.edu:1721.1/83835"},"canonical_url":"https://search.dev.ndltd.org/etd/mit/oai:dspace.mit.edu:1721.1/83835","repository":{"repo_id":"mit","name":"MIT","base_url":"https://dspace.mit.edu/oai/request"},"display":{"title":"Maximum containment : the most controversial labs in the world","abstract":"In 2002, following the September 11th attacks and the anthrax letters, the United States allocated money to build two maximum containment biology labs. Called Biosafety Level 4 (BSL-4) facilities, these labs were built to research new vaccines, diagnostics, and treatments for emerging infectious diseases, potential biological weapons, and to contribute to the nation's biodefense. These labs were not the first dramatic reaction to the threat of biowarfare and are in fact, one product of a long history of the country's contentious relationship with biological weapons. Of the two labs created, Boston University Medical Center's National Infectious and Emerging Disease Laboratories (NEIDL) has remained the more controversial given the urban community it resides in. However, increasingly the mandate of these labs has been expanded from biodefense to all infectious disease, regardless of their potential probability for use as a weapon. These include looking at pathogens that could potentially cause a pandemic like SARS, ebola, or smallpox. The repurposing of these labs could make them an invaluable contributor to the United States public health system.","abstract_html":"In 2002, following the September 11th attacks and the anthrax letters, the United States allocated money to build two maximum containment biology labs. Called Biosafety Level 4 (BSL-4) facilities, these labs were built to research new vaccines, diagnostics, and treatments for emerging infectious diseases, potential biological weapons, and to contribute to the nation's biodefense. These labs were not the first dramatic reaction to the threat of biowarfare and are in fact, one product of a long history of the country's contentious relationship with biological weapons. Of the two labs created, Boston University Medical Center's National Infectious and Emerging Disease Laboratories (NEIDL) has remained the more controversial given the urban community it resides in. However, increasingly the mandate of these labs has been expanded from biodefense to all infectious disease, regardless of their potential probability for use as a weapon. These include looking at pathogens that could potentially cause a pandemic like SARS, ebola, or smallpox. The repurposing of these labs could make them an invaluable contributor to the United States public health system.","abstract_has_math":false,"creators":["Bruzek, Alison K. (Allison Kim)"],"institution":"Massachusetts Institute of Technology","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Massachusetts Institute of Technology. Department of Comparative Media Studies","school":null,"contributors":[],"advisors":["Philip Hilts."],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013","date_published":"2013","updated_at":"2026-07-22T22:21:25Z","subjects":["Comparative Media Studies."],"languages":["eng"],"rights":["M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission."],"rights_urls":["http://dspace.mit.edu/handle/1721.1/7582"],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/1721.1/83835","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Philip Hilts."]},{"key":"dc:contributor.department","label":"Department","values":["Massachusetts Institute of Technology. Department of Comparative Media Studies","MIT Comparative Media Studies/Writing","Massachusetts Institute of Technology. Graduate Program in Science Writing"]},{"key":"dc:contributor.other","label":"Dc Contributor Other","values":["Massachusetts Institute of Technology. Department of Comparative Media Studies."]},{"key":"dc:creator","label":"Author","values":["Bruzek, Alison K. (Allison Kim)"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-01-09T20:00:13Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-01-09T20:00:13Z"]},{"key":"dc:date.issued","label":"Date","values":["2013"]},{"key":"dc:publisher","label":"Institution","values":["Massachusetts Institute of Technology"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Comparative Media Studies."]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission."]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://dspace.mit.edu/handle/1721.1/7582"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/1721.1/83835"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (S.M. in Science Writing)--Massachusetts Institute of Technology, Dept. of Comparative Media Studies, 2013.","Cataloged from PDF version of thesis.","Includes bibliographical references (pages 40-51)."]},{"key":"dc:description.abstract","label":"Abstract","values":["In 2002, following the September 11th attacks and the anthrax letters, the United States allocated money to build two maximum containment biology labs. Called Biosafety Level 4 (BSL-4) facilities, these labs were built to research new vaccines, diagnostics, and treatments for emerging infectious diseases, potential biological weapons, and to contribute to the nation's biodefense. These labs were not the first dramatic reaction to the threat of biowarfare and are in fact, one product of a long history of the country's contentious relationship with biological weapons. Of the two labs created, Boston University Medical Center's National Infectious and Emerging Disease Laboratories (NEIDL) has remained the more controversial given the urban community it resides in. However, increasingly the mandate of these labs has been expanded from biodefense to all infectious disease, regardless of their potential probability for use as a weapon. These include looking at pathogens that could potentially cause a pandemic like SARS, ebola, or smallpox. The repurposing of these labs could make them an invaluable contributor to the United States public health system."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["S.M.in Science Writing"]},{"key":"dc:title","label":"Title","values":["Maximum containment : the most controversial labs in the world"]}]}],"canonical_facts":{"dc:contributor.advisor":["Philip Hilts."],"dc:contributor.department":["Massachusetts Institute of Technology. Department of Comparative Media Studies","MIT Comparative Media Studies/Writing","Massachusetts Institute of Technology. Graduate Program in Science Writing"],"dc:contributor.other":["Massachusetts Institute of Technology. Department of Comparative Media Studies."],"dc:creator":["Bruzek, Alison K. (Allison Kim)"],"dc:date.accessioned":["2014-01-09T20:00:13Z"],"dc:date.available":["2014-01-09T20:00:13Z"],"dc:date.issued":["2013"],"dc:description":["Thesis (S.M. in Science Writing)--Massachusetts Institute of Technology, Dept. of Comparative Media Studies, 2013.","Cataloged from PDF version of thesis.","Includes bibliographical references (pages 40-51)."],"dc:description.abstract":["In 2002, following the September 11th attacks and the anthrax letters, the United States allocated money to build two maximum containment biology labs. Called Biosafety Level 4 (BSL-4) facilities, these labs were built to research new vaccines, diagnostics, and treatments for emerging infectious diseases, potential biological weapons, and to contribute to the nation's biodefense. These labs were not the first dramatic reaction to the threat of biowarfare and are in fact, one product of a long history of the country's contentious relationship with biological weapons. Of the two labs created, Boston University Medical Center's National Infectious and Emerging Disease Laboratories (NEIDL) has remained the more controversial given the urban community it resides in. However, increasingly the mandate of these labs has been expanded from biodefense to all infectious disease, regardless of their potential probability for use as a weapon. These include looking at pathogens that could potentially cause a pandemic like SARS, ebola, or smallpox. The repurposing of these labs could make them an invaluable contributor to the United States public health system."],"dc:description.degree":["S.M.in Science Writing"],"dc:identifier.uri":["http://hdl.handle.net/1721.1/83835"],"dc:language.iso":["eng"],"dc:publisher":["Massachusetts Institute of Technology"],"dc:rights":["M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission."],"dc:rights.uri":["http://dspace.mit.edu/handle/1721.1/7582"],"dc:subject":["Comparative Media Studies."],"dc:title":["Maximum containment : the most controversial labs in the world"],"dc:type":["Thesis"]},"updated_at":"2026-07-22T22:21:25Z"}